share_log

Navigating 14 Analyst Ratings For Amgen

Navigating 14 Analyst Ratings For Amgen

浏览安进的14个分析师评级
Benzinga ·  10/22 15:01  · 评级/大行评级
Analysts' ratings for Amgen (NASDAQ:AMGN) over the last quarter vary from bullish to bearish, as provided by 14 analysts.
上个季度安进(纳斯达克股票代码:AMGN)的分析师评级从看好到看淡不一,共有14位分析师提供。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照,展示了情绪在过去30天中的演变情况,并将其与之前的月份进行比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $349.36, a high estimate of $405.00, and a low estimate of $215.00. This upward trend is apparent, with the current average reflecting a 4.55% increase from the previous average price target of $334.17.
分析师通过对12个月价格目标的评估提供更深入的见解,显示出平均目标为349.36美元,高估为405.00美元,低估为215.00美元。这种上升趋势是明显的,当前平均值反映比之前的平均价格目标334.17美元增长了4.55%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级:全面解析
A comprehensive examination of how...
最近的分析...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发